Navigation Links
AEGON and Right To Play Announce Global Partnership
Date:7/3/2008

THE HAGUE, The Netherlands, July 4 /PRNewswire-FirstCall/ -- AEGON N.V. and the international humanitarian organization Right To Play announce a new global partnership to extend the organization's mission to help children in deprived areas of Sudan, Uganda, Ghana and China. AEGON N.V. has donated EUR 1 million as part of a three year partnership that will extend through the 2010 Winter Olympic games in Vancouver, Canada.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080704/311773 )

Right To Play, founded by four-time Olympic Gold medalist and current CEO Johann Olav Koss, uses sport and play programs to improve health, develop life skills, and foster peace for children and communities in some of the most disadvantaged areas of the world. Currently, Right To Play has projects in over twenty countries in Africa, Asia and the Middle East. Its programs target the most vulnerable, including young girls, the disabled, children affected by HIV and AIDS, street children, former child combatants and refugees.

"AEGON is honored to join with Right To Play in improving the lives of children who are forced to endure some of the most desperate circumstances around the world," said AEGON CEO Alexander Wynaendts. "We are committed to making a difference in the communities where we work and live, and also in places where we may not necessarily be active in business but where we can still help to create better futures through respected and effective organizations such as Right To Play."

Right To Play was built in the 1990s on the power and values of sport, demonstrated by the engagement of Athlete Ambassadors from more than 40 countries who serve as positive role models and advocates for children. AEGON has long sponsored high-achieving athletes to support athletic excellence and reinforce the value it places on teamwork, communication, respect and trust. The relationship between AEGON and Right To Play dates back to 2004, when AEGON's Dutch organization - AEGON The Netherlands - signed a three year partnership. Among the activities developed by AEGON The Netherlands to raise funds for and awareness about Right To Play is the annual AEGON Right To Play Run for its business partners, employees and their families. Proceeds of the event in 2007, totaling EUR 340,000, have been used to support Right To Play activities in regions affected by war, poverty and disease.

Johann Olav Koss stated: "The relationship that AEGON and Right To Play have built up over the last 4 years has proven itself as a golden combination. With the expansion of the partnership, we are now entering a new phase in which AEGON will support Right To Play in implementing sports and play projects and building capacity and programs as a basis for future growth of the organization. The long-term commitment of AEGON and the passionate involvement of its employees is a great example of a worldwide respected company taking its social responsibility by contributing to communities in the most disadvantaged areas in the world."

In addition to supporting Right To Play, AEGON also funds international cancer research, and other education, social and civic organizations aimed at addressing quality of life issues and creating opportunity for people and communities in the Americas, Europe and Asia.

AEGON

AEGON is one of the world's largest life insurance and pension groups, and a strong provider of investment products. AEGON empowers local business units to identify and provide products and services that meet the evolving needs of customers, using distribution channels best suited to local markets. AEGON takes pride in balancing a local approach with the power of an expanding global operation.

With headquarters in The Hague, the Netherlands, AEGON companies employ approximately 30,000 people worldwide. AEGON's businesses serve millions of customers in over twenty markets throughout the Americas, Europe, and Asia.

Respect, quality, transparency and trust constitute AEGON's core values as the company continually strives to meet the expectations of customers, shareholders, employees and business partners. AEGON is driven to deliver new thinking with the ambition to be the best in the industry.

RIGHT TO PLAY

Right To Play is a non profit athlete-driven international humanitarian organization that uses specially-designed sport and play programs to improve health, build life skills, and foster peace for children and communities affected by war, poverty, disease. Right To Play has projects in more than twenty countries in Africa, Asia and the Middle East. Its key areas of focus are basic education and child development, health promotion and disease prevention, conflict prevention and peace education, and community development.

Group Corporate Communications & Investor Relations

Media relations

Phone: +31-(0)70-344-8344

E-mail: gcc-ir@aegon.com

Investor relations

Phone: +31-(0)70-344-8305

or +1-877-548-9668 - toll free USA only

E-mail: ir@aegon.com

Website http://www.aegon.com


'/>"/>
SOURCE AEGON N.V.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Renowned Iowa Orthopaedic Surgeon, John Albright, MD, Inducted into Sports Medicine Hall of Fame
2. World's First USB Duplicator with Copy Protection and Digital Rights Management Available from Nexcopy and TrusCont Ltd.
3. SleepRight(R) Dental Guard Receives FDA Clearance
4. Young Man With Severe Disabilities Wins Right to Services From State Enabling Him to Live At Home
5. New York Legislators Kill Bill for Grieving Mothers. Womens Rights Activist stands up for some women and not others.
6. American Right to Life Endorses U.S. Senator Roger Wickers Life at Conception Act
7. May 2008 issue on conflict and crisis settings: Promoting sexual and reproductive rights
8. China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products
9. Professor Chon Abraham of the Mason School of Business at The College of William & Mary named Fulbright Scholar
10. Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
11. Duke chemist has new way to tell right from left
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: